您的购物车当前为空
WS6 是一种具有促beta 细胞增生作用的新型小分子,在啮齿类动物和人源原发性胰岛中EC50值为0.28uM。


为众多的药物研发团队赋能,
让新药发现更简单!
WS6 是一种具有促beta 细胞增生作用的新型小分子,在啮齿类动物和人源原发性胰岛中EC50值为0.28uM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 239 | In Stock | |
| 2 mg | ¥ 323 | In Stock | |
| 5 mg | ¥ 496 | In Stock | |
| 10 mg | ¥ 795 | In Stock | |
| 25 mg | ¥ 1,480 | In Stock | |
| 50 mg | ¥ 2,380 | In Stock | |
| 100 mg | ¥ 3,330 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 619 | In Stock |
WS6 相关产品
| 产品描述 | WS6, a β cell proliferation inducer, regulates Erb3 binding protein-1 (EBP1) and the IκB kinase pathway. |
| 靶点活性 | Proliferation (β cells):0.28 μM |
| 体外活性 | 在切除β细胞的RIP-DTA小鼠模型中,给口服WS6(50 mg/kg )能够β细胞增殖,从而改善糖尿病. |
| 体内活性 | 在R7T1细胞中(EC50=0.28 μM),WS6通过Erb3结合蛋白-1和IκB激酶信号通路作用,诱导细胞增殖。 |
| 激酶实验 | PARP assays are conducted in a buffer containing 50 mM Tris (pH 8.0), 1 mM DTT, 1.5 μM [3H]NAD+?(1.6 μCi/mmol), 200 nM biotinylated histone H1, 200 nM slDNA, and 1 nM PARP-1 or 4 nM PARP-2 enzyme. Reactions are terminated with 1.5 mM benzamide, transferred to streptavidin Flash plates, and counted using a TopCount microplate scintillation counter. |
| 细胞实验 | R7T1 cells are growth-arrested by removal of doxycycline for 2 days and plated into 384-well plates at a density of 3,000 cells/well in growth medium. Β cell proliferation is assessed using CellTiter Glo after 4 days. Fold increase in cell number is calculated by normalizing compound-treated wells to the median of DMSO-treated wells. (Only for Reference) |
| 分子量 | 568.59 |
| 分子式 | C29H31F3N6O3 |
| CAS No. | 1421227-53-3 |
| Smiles | C(C1=C(C(F)(F)F)C=C(NC(CC2=CC=C(OC=3C=C(NC(=O)C4CC4)N=CN3)C=C2)=O)C=C1)N5CCN(C)CC5 |
| 密度 | 1.374 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 93 mg/mL (163.56 mM), Sonication is recommended. Ethanol: 93 mg/mL (163.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (5.8 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
| ||||||||||||||||||||||||||||||||||||
评论内容